Health X Platform board to meet on May 30 for Q4FY26 results

Health X Platform Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the audited standalone and consolidated financial results of the company for the quarter and financial year ended March 31, 2026.

The meeting is being convened pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review the performance of the company for the fourth quarter of the fiscal year 2026 and the full fiscal year.

In a disclosure related to the upcoming results, the company informed that the trading window for dealing in the securities of the company shall remain closed. This closure is effective until 48 hours after the declaration of the financial results to the stock exchanges, continuing from the previous closure notice dated March 25, 2026.

Key Meeting Details

Particulars	Details
Meeting Date	May 30, 2026
Day	Saturday
Purpose	Consideration of Audited Standalone and Consolidated Financial Results for Q4 and FY ended March 31, 2026
Trading Window Status	Closed till 48 hours after result declaration

The company, formerly known as Sastasundar Ventures Limited, has its registered office at Azimganj House, 2nd Floor, 7, Abanindra Nath Thakur Sarani, Kolkata. The intimation was signed by Pratap Singh, Company Secretary and Compliance Officer.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.64%	+7.33%	+16.95%	-1.54%	+16.82%	+59.12%

Health X Platform Limited (formerly known as sastasundar ventures Limited) has informed the stock exchanges of the completion of the transfer of the entire equity stake held by Mitsubishi Corporation in Sastasundar Healthbuddy Limited, a material subsidiary of the Company, to Envision India Fund. The transaction was completed on May 12, 2026, following the earlier disclosure made on February 25, 2026, regarding the execution of a Share Purchase Agreement by Sastasundar Healthbuddy Limited.

Transaction Details

The completed transaction involved the transfer of Mitsubishi Corporation's full shareholding in Sastasundar Healthbuddy Limited. The key details of the transaction are outlined below:

Parameter:	Details
Shares Transferred:	10,13,766 (Ten Lakh Thirteen Thousand Seven Hundred Sixty-Six) equity shares
Stake Transferred:	4.68% of total issued and paid-up share capital
Seller:	Mitsubishi Corporation
Buyer:	Envision India Fund
Transaction Completion Date:	May 12, 2026
Company Involved:	Sastasundar Healthbuddy Limited (material subsidiary)

As a result of the transfer, Mitsubishi Corporation has ceased to be a shareholder of Sastasundar Healthbuddy Limited.

Board Acknowledgement and Regulatory Disclosure

The board of directors of Sastasundar Healthbuddy Limited took note of the said transfer at its board meeting held on May 15, 2026. Health X Platform Limited received the intimation from Sastasundar Healthbuddy Limited on May 15, 2026, at 10:46 AM. The disclosure has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The intimation was submitted by Pratap Singh, Company Secretary and Compliance Officer of Health X Platform Limited, in accordance with applicable regulatory requirements.